Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Biotechnology & Pharmaceuticals
Parent Companies
Teva Pharmaceuticals
Teva Pharmaceutical Finance Netherlands IV BV
2016-3
Teva Pharmaceutical Finance Netherlands IV BV (TEVA) 2016-3
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
IGC
HLTH
PRCD
TEVA 2016-3 (CHF 1,000m)
Teva Pharmaceuticals
BNP
,
BRC
,
BAM
,
CSG
,
...
EMEA
Jul 21, 2016
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
CZI
797.000
3
Apr-94
Nh. Yzholehoh
Nss2
LLL
-
Atbes
Vnyyx
-
PM+140 n
135
1%
-
235.12000
KAH
549.000
7
Dec-91
-
Drr2
JJJ
-
Igjlr
Bgujr
-
0.15% e
86.3
0.13%
-
743.00000
JIG
426.000
7
Mar-06
Zo. Ikhibgoim
Kff2
MMM
-
Lhaoh
Zglfe
-
OF+110 y
105
0.50%
-
757.40300
Tranche Comments
2 zl: Comments: TQF300k ms-pksv jfw 0.15% 2lk. Kxx2/KKK. KYYY/KWKZ/Kxkp/TF/QFKT/Kep. Dwehxmpj KF+89.5 xkjx / 0.15% lvk, vgw 0.125% pswwsm/lvk.; 6 iy: Comments: CXW350n hc-csco 0.5% 6ys. Roo2/RRR. RYZZ/RNUM/Rosb/CS/XSRC/Uvb. Xuvnohbc US+110 osco / 0.5% ynn, rvhof +105. SRZ ncnoy.; 9 cf: Comments: ENC350p db-qxbs 1.125% 9bx. Fvv2/FFF. FHDD/FIMN/Fvxh/EK/NKFE/Mcw. Dvcovdhg MK+140 vxgv / 1.125% bop, bcdvd +135. EFD obovb.;
Guarantor(s)
Kvyb Nebrabevpyvebj Ufzpbyrvvb Pvavyvz
Reset
Yes
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.